CDMOs offering Technology Transfer with Biologics (Monoclonal Antibodies)
43 published
43 published CDMOs match Technology Transfer and Biologics (Monoclonal Antibodies).
Locations in this set include United States, Germany, China, Japan, United Kingdom, and India.
Capabilities that show up most often in this set: CMC Analytical Development, Process Development, Quality Control Testing, Formulation Development, and Stability Testing & Storage.
Matching companies
Wheeler BioOklahoma-based CDMO specializing in antibody-based therapeutics from cell line development through cGMP manufacturing. Offers ModularCMC platform with phase-appropriate work packages and high-touch project management.
WuXi BiologicsGlobal biologic CDMO offering end-to-end solutions from discovery to commercialization.
WuXi XDCWuXi XDC is a leading CRDMO offering integrated discovery, development, and cGMP manufacturing services for antibody drug conjugates (ADCs) and bioconjugates, with proximately located facilities that reduce development timelines and costs.
Markdown mirror: /explore/technology-transfer/biologics-monoclonal-antibodies.md